MPI 5004
Alternative Names: IntraDose™-MTX; Methotrexate/epinephrine injectable gelLatest Information Update: 09 Sep 2009
At a glance
- Originator Novartis
- Class Antineoplastics; Pterins; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Head and neck cancer; Liver cancer; Prostate cancer; Solid tumours
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 10 May 1999 Preclinical data have been added to the pharmacodynamics and adverse events sections
- 13 May 1996 Suspended-II for Head and neck cancer in USA (Intratumoural)